Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Telix to quote shares issued under non-executive director rights plan

TLX: $13.06 +2.11% · MC: $4.7B

Telix Pharmaceuticals has applied to quote ordinary shares issued under its Australian Non-Executive Director Rights Plan. The issue adds a small number of shares to the company’s existing quoted capital.

Source announcements: 2026-10-28 17:25 to 2026-10-28 17:25 Sydney time
Story updated 2026-10-28 17:26 Sydney time
SourcesApplication for quotation of securities - TLX
Comments